PAQR6 is significantly upregulated in PRAD tissues and is closely associated with a higher pathological stage of the tumor, ratio of free-prostate-specific antigen/total-PSA, Gleason score, and shorter OS [46]. Here, PAQR6 is linked to neoplasm.